[HTML][HTML] Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity?
…, N Gent, A Johnsen, RM Anderson, T Ward - The Lancet …, 2021 - thelancet.com
Many nations are pursuing the rollout of SARS-CoV-2 vaccines as an exit strategy from
unprecedented COVID-19-related restrictions. However, the success of this strategy relies …
unprecedented COVID-19-related restrictions. However, the success of this strategy relies …
Deepmind lab
… The interaction with the platform is lock-stepped, with the engine stepped forward one
simulation step (or multiple with repeated actions, if desired) at a time, according to a user-…
simulation step (or multiple with repeated actions, if desired) at a time, according to a user-…
Trends, regional variation, and clinical characteristics of COVID-19 vaccine recipients: a retrospective cohort study in 23.4 million patients using OpenSAFELY
Background On December 8th 2020, NHS England administered the first COVID-19 vaccination
as part of an ambitious vaccination programme during a global health emergency. Aims …
as part of an ambitious vaccination programme during a global health emergency. Aims …
Real-time monitoring of COVID-19 dynamics using automated trend fitting and anomaly detection
As several countries gradually release social distancing measures, rapid detection of new
localized COVID-19 hotspots and subsequent intervention will be key to avoiding large-scale …
localized COVID-19 hotspots and subsequent intervention will be key to avoiding large-scale …
Impala: Scalable distributed deep-rl with importance weighted actor-learner architectures
In this work we aim to solve a large collection of tasks using a single reinforcement learning
agent with a single set of parameters. A key challenge is to handle the increased amount of …
agent with a single set of parameters. A key challenge is to handle the increased amount of …
Mahler measure and entropy for commuting automorphisms of compact groups
D Lind, K Schmidt, T Ward - Inventiones mathematicæ, 1990 - Springer
We compute the joint entropy ofd commuting automorphisms of a compact metrizable group.
LetR d = ℤ[u 1 ±1 ,...,[d 1 ±1 ] be the ring of Laurent polynomials ind commuting variables, …
LetR d = ℤ[u 1 ±1 ,...,[d 1 ±1 ] be the ring of Laurent polynomials ind commuting variables, …
[HTML][HTML] Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in …
…, R Croker, S Bacon, G Hickman, T Ward… - The Lancet …, 2022 - thelancet.com
Background The risk of severe COVID-19 outcomes in people with immune-mediated
inflammatory diseases and on immune-modifying drugs might not be fully mediated by …
inflammatory diseases and on immune-modifying drugs might not be fully mediated by …
[HTML][HTML] Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the …
…, SCJ Bacon, G Hickman, D Evans, T Ward… - The Lancet public …, 2023 - thelancet.com
Background COVID-19 has been shown to differently affect various demographic and
clinical population subgroups. We aimed to describe trends in absolute and relative COVID-19-…
clinical population subgroups. We aimed to describe trends in absolute and relative COVID-19-…
Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records in situ using OpenSAFELY
Background Long COVID describes new or persistent symptoms at least 4 weeks after onset
of acute COVID-19. Clinical codes to describe this phenomenon were recently created. Aim …
of acute COVID-19. Clinical codes to describe this phenomenon were recently created. Aim …
Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the …
…, S Davy, J Cockburn, CE Morton, G Hickman, T Ward… - bmj, 2022 - bmj.com
Objective To compare the effectiveness of sotrovimab (a neutralising monoclonal antibody)
with molnupiravir (an antiviral) in preventing severe outcomes of covid-19 in adult patients …
with molnupiravir (an antiviral) in preventing severe outcomes of covid-19 in adult patients …